Differences according to age and sex among patients with malignant pleural effusion as a presentation form of cancer

Maria Teresa Perez Warnisher (Madrid, Spain), Maria Teresa Perez Warnisher, Rosario Melchor, Maite Rio, Beatriz Morales, Eva de Santiago, Ismael Ali, Marisi Verdugo, Mercedes Izquierdo, Raquel Pérez, Ignacio Granda, Barbara Steen, Yolanda Martínez, Victoria Villena, Nuria Abaad

Source: International Congress 2016 – Malignant pleural disease: diagnosis and management
Session: Malignant pleural disease: diagnosis and management
Session type: Poster Discussion
Number: 3395
Disease area: Thoracic oncology

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Maria Teresa Perez Warnisher (Madrid, Spain), Maria Teresa Perez Warnisher, Rosario Melchor, Maite Rio, Beatriz Morales, Eva de Santiago, Ismael Ali, Marisi Verdugo, Mercedes Izquierdo, Raquel Pérez, Ignacio Granda, Barbara Steen, Yolanda Martínez, Victoria Villena, Nuria Abaad. Differences according to age and sex among patients with malignant pleural effusion as a presentation form of cancer. Eur Respir J 2016; 48: Suppl. 60, 3395

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Malignant pleural effusion as the initial manifestation of gynecological malignancies
Source: International Congress 2016 – Malignant pleural disease: diagnosis and management
Year: 2016


Malignant pleural effusion (MPE) as debut of cancer
Source: International Congress 2015 – Malignant pleural effusions and mesothelioma
Year: 2015


Risk of occult pleural infection in patients with malignant effusions
Source: Annual Congress 2013 –Diagnosis and management of pleural and mediastinal diseases
Year: 2013


Survival of non small cell lung carcinoma patients with malignant pleural effusions
Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series
Year: 2014


Lent score validation on patients with malignant pleural effusion
Source: International Congress 2016 – Malignant pleural disease: diagnosis and management
Year: 2016

Predictive parameters of survival in malignant pleural effusion
Source: International Congress 2015 – Malignant pleural effusions and mesothelioma
Year: 2015


Ideal volume sampling in the diagnosis of malignant pleural effusions. Just how much is really enough?
Source: Annual Congress 2013 –Progress in bronchoscopy and pathology techniques for diagnosis of thoracic malignancies
Year: 2013

What outcome after pleurodesis in malignant pleural effusion in lung cancer?
Source: International Congress 2015 – Mediastinal tumors, malignant pleural mesothelioma and other rare tumors
Year: 2015


Significance of age, tumor location and histological subtype in lung cancer with brain metastasis
Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer
Year: 2013


Benign lung tumors: Presentation, diagnosis, and outcome
Source: Annual Congress 2013 –Other thoracic tumours, particular circumstances and rare cases
Year: 2013


Rare localization of NUT midline carcinoma revealed by pneumonia and pleural effusion in a 13 years old patient: A case report
Source: International Congress 2015 – Thoracic oncology around the world: rare cases and local features
Year: 2015


The utility of survivin mRNA as a diagnostic biomarker in lung cancer with malignant pleural effusion
Source: Annual Congress 2013 –Fundamental biology of malignant pleural effusions
Year: 2013



Role of Dr-70 immunoassay in suspected malignant pleural effusion
Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer
Year: 2013


Elevated survivin is associated with a reduced survival in patients with malignant pleural effusion
Source: Annual Congress 2013 –Fundamental biology of malignant pleural effusions
Year: 2013

General characteristics and therapeutic options in lung cancer in Turkey
Source: International Congress 2015 – Thoracic oncology around the world: rare cases and local features
Year: 2015


Talc pleurodesis for malignant pleural effusion - effect on survival: Case-control follow-up study
Source: International Congress 2014 – Diagnosis and treatment of pleural mesothelioma
Year: 2014


Characteristics of malignant pleural effusions. Review of one-year data from a large tertiary centre
Source: Annual Congress 2013 –Diagnosis and management of pleural and mediastinal diseases
Year: 2013


Outcome of patients with non specific pleuritis after medical thoracoscopy
Source: International Congress 2016 – Malignant pleural disease: diagnosis and management
Year: 2016


Pleural mesothelioma with solitary simultaneous subcutaneous tissue metastasis of the abdominal wall at diagnosis - First clinical documentation
Source: Annual Congress 2013 –Other thoracic tumours, particular circumstances and rare cases
Year: 2013


A feasibility study of pulmonary rehabilitation at home in patients with lung cancer or malignant pleural mesothelioma treated by (radio-)chemotherapy
Source: International Congress 2014 – Best abstracts in pulmonary rehabilitation and exercise training
Year: 2014